Just Biotherapeutics

Tech-driven biologics development at lower cost

Just Biotherapeutics is developing an integrated technology platform to accelerate the development and manufacturing of high-quality biologics at a significantly lower cost, and to help broaden global biologic access.
  • Domain
  • Investment type
    Direct equity
  • Status
  • Initial investment
    Series A-2
  • Partnered in
  • Headquarters
  • Program strategy
    Vaccine Development

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.